Name of this trial: Artemide Lung-03 What type of cancer is this for? Metastatic Non-Small Cell Lung Cancer (NSCLC) Who is this trial for? Participants who have not had treatment for their metastatic non-squamous lung cancer. Early-stage treatment in curative setting is permitted. What biomarkers are involved? PD-L1 What is the National Clinical Trial #?
Phone: (800) 411-7999
